Compliance Rate

Compliance Rate 51.23%
Compliant submissions 187
Incompliant submissions 178
Total trials 365

My Organizations' Clinical Trials

Showing 2350 of 2400 entries
View as:

Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age

Phase: N/A Priority: Normal
NCT ID: NCT03102034 Org: User:
Start: 04/06/17 End: 05/25/18 Due: 05/25/19

H5N8 Mix and Match With or Without AS03 or MF59 in Healthy Adults: Immunology

Phase: N/A Priority: Normal
NCT ID: NCT03014310 Org: User:
Start: 01/09/17 End: 12/19/18 Due: 12/19/19

Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status

Phase: N/A Priority: Normal
NCT ID: NCT01040091 Org: User:
Start: 12/31/09 End: 04/30/14 Due: 04/30/15

Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug

Phase: N/A Priority: Normal
NCT ID: NCT00318747 Org: User:
Start: 04/30/06 End: 11/30/06 Due: 11/30/07

Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV

Phase: N/A Priority: Normal
NCT ID: NCT00006441 Org: User:
Start: 02/28/03 End: 10/31/08 Due: 10/31/09

Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00308412 Org: User:
Start: 06/30/06 End: 04/30/10 Due: 04/30/11

Proteomic Profiling for Influenza Vaccination - FluMist

Phase: N/A Priority: Normal
NCT ID: NCT00385281 Org: User:
Start: 10/31/06 End: 04/30/07 Due: 04/30/08

Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT02186626 Org: User:
Start: 02/28/14 End: 07/31/16 Due: 07/31/17

Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso

Phase: N/A Priority: Normal
NCT ID: NCT02663700 Org: User:
Start: 04/07/16 End: 12/17/18 Due: 12/17/19

The Safety and Effectiveness of Zidovudine in the Treatment of Patients With Early AIDS Related Complex

Phase: N/A Priority: Normal
NCT ID: NCT00001011 Org: User:
Start: - End: 02/28/95 Due: 02/28/96

Phase 1 Study of dmLT ID Vaccination in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT02531685 Org: User:
Start: 06/02/16 End: 05/04/20 Due: 05/04/21

A Double-Blind Placebo-Control Dose Escalating Study to Evaluate the Safety and Immunogenicity of dmLT by Oral, Sublingual and Intradermal Vaccination in Adults Residing in an Endemic Area

Phase: N/A Priority: Normal
NCT ID: NCT03548064 Org: User:
Start: 03/10/19 End: 12/31/20 Due: 12/31/21

A Phase 2 Randomized Multisite Trial to Inform Public Health Strategies Involving the Use of MVA-BN Vaccine for Mpox

Phase: N/A Priority: Normal
NCT ID: NCT05740982 Org: User:
Start: 03/22/23 End: 08/28/24 Due: 08/28/25

Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants

Phase: N/A Priority: Normal
NCT ID: NCT03589768 Org: User:
Start: 01/24/19 End: 07/01/20 Due: 07/01/21

Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03186781 Org: User:
Start: 10/25/17 End: 09/03/19 Due: 09/03/20

Microbial, Immune, and Metabolic Perturbations by Antibiotics (MIME Study)

Phase: N/A Priority: Normal
NCT ID: NCT02707042 Org: User:
Start: 03/22/17 End: 12/01/25 Due: 12/01/26

Study of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT05660980 Org: User:
Start: 01/24/24 End: 07/27/27 Due: 07/27/28

H1N1v Virus Challenge Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04044352 Org: User:
Start: 10/22/19 End: 03/02/20 Due: 03/02/21

The Effects of Anti-HIV Drugs on the HIV Virus in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00006442 Org: User:
Start: - End: - Due: -

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children

Phase: N/A Priority: Normal
NCT ID: NCT01968083 Org: User:
Start: 10/03/13 End: 05/31/15 Due: 05/31/16

The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children

Phase: N/A Priority: Normal
NCT ID: NCT00001054 Org: User:
Start: - End: 01/31/01 Due: 01/31/02

Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT01428700 Org: User:
Start: 08/31/11 End: 01/31/13 Due: 01/31/14

Safety and Dose Study of Peramivir for Influenza Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00297050 Org: User:
Start: 02/23/06 End: 11/14/06 Due: 11/14/07

The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA)

Phase: N/A Priority: Normal
NCT ID: NCT00822276 Org: User:
Start: 02/28/09 End: 11/30/09 Due: 11/30/10

Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT00515047 Org: User:
Start: 05/31/06 End: 01/31/11 Due: 01/31/12